BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29216845)

  • 1. A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination.
    Shi M; An Q; Ainslie KEC; Haber M; Orenstein WA
    BMC Infect Dis; 2017 Dec; 17(1):757. PubMed ID: 29216845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the bias of estimates of influenza vaccine effectiveness from test-negative studies.
    Ainslie KEC; Shi M; Haber M; Orenstein WA
    Vaccine; 2017 Dec; 35(52):7297-7301. PubMed ID: 29146382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic.
    Ainslie KEC; Haber M; Orenstein WA
    Vaccine; 2019 Mar; 37(14):1987-1993. PubMed ID: 30833155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The test-negative design for estimating influenza vaccine effectiveness.
    Jackson ML; Nelson JC
    Vaccine; 2013 Apr; 31(17):2165-8. PubMed ID: 23499601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A probability model for evaluating the bias and precision of influenza vaccine effectiveness estimates from case-control studies.
    Haber M; An Q; Foppa IM; Shay DK; Ferdinands JM; Orenstein WA
    Epidemiol Infect; 2015 May; 143(7):1417-26. PubMed ID: 25147970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Dynamic Model for Evaluation of the Bias of Influenza Vaccine Effectiveness Estimates From Observational Studies.
    Ainslie KEC; Shi M; Haber M; Orenstein WA
    Am J Epidemiol; 2019 Feb; 188(2):451-460. PubMed ID: 30329006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The case test-negative design for studies of the effectiveness of influenza vaccine.
    Foppa IM; Haber M; Ferdinands JM; Shay DK
    Vaccine; 2013 Jun; 31(30):3104-9. PubMed ID: 23624093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of selection bias on vaccine effectiveness estimates from test-negative studies.
    Jackson ML; Phillips CH; Benoit J; Kiniry E; Madziwa L; Nelson JC; Jackson LA
    Vaccine; 2018 Jan; 36(5):751-757. PubMed ID: 29254838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Confounding Bias in Coronavirus Disease 2019 (COVID-19) and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors.
    Doll MK; Pettigrew SM; Ma J; Verma A
    Clin Infect Dis; 2022 Aug; 75(1):e564-e571. PubMed ID: 35325923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings.
    Foppa IM; Ferdinands JM; Chaves SS; Haber MJ; Reynolds SB; Flannery B; Fry AM
    Int J Epidemiol; 2016 Dec; 45(6):2052-2059. PubMed ID: 26979985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness.
    Jackson ML; Rothman KJ
    Vaccine; 2015 Mar; 33(11):1313-6. PubMed ID: 25659280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons.
    Thompson MG; Li DK; Shifflett P; Sokolow LZ; Ferber JR; Kurosky S; Bozeman S; Reynolds SB; Odouli R; Henninger ML; Kauffman TL; Avalos LA; Ball S; Williams JL; Irving SA; Shay DK; Naleway AL;
    Clin Infect Dis; 2014 Feb; 58(4):449-57. PubMed ID: 24280090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of influenza vaccination against medically-attended illnesses in Hong Kong across three years with different degrees of vaccine match, 2014-17.
    Tam YH; Ng TWY; Chu DKW; Fang VJ; Cowling BJ; Malik Peiris JS; Ip DKM
    Vaccine; 2018 Oct; 36(41):6117-6123. PubMed ID: 30190121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe.
    Maurel M; Mazagatos C; Goerlitz L; Oroszi B; Hooiveld M; Machado A; Domegan L; Ilić M; Popescu R; Sève N; Martínez-Baz I; Larrauri A; Buda S; Túri G; Meijer A; Gomez V; O'Donnell J; Mlinarić I; Timnea O; Diez AO; Dürrwald R; Horváth JK; Dijkstra F; Rodrigues AP; McKenna A; Filipović SK; Lazar M; Kaczmarek M; Bacci S; Kissling E;
    Vaccine; 2024 Jun; 42(16):3547-3554. PubMed ID: 38704257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimates of 2012/13 influenza vaccine effectiveness using the case test-negative control design with different influenza negative control groups.
    Nunes B; Machado A; Guiomar R; Pechirra P; Conde P; Cristovão P; Falcão I
    Vaccine; 2014 Jul; 32(35):4443-4449. PubMed ID: 24962756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early estimates of seasonal influenza vaccine effectiveness--United States, January 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jan; 62(2):32-5. PubMed ID: 23325354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study.
    Wongsurakiat P; Maranetra KN; Wasi C; Kositanont U; Dejsomritrutai W; Charoenratanakul S
    Chest; 2004 Jun; 125(6):2011-20. PubMed ID: 15189916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right sizing for vaccine effectiveness studies: how many is enough for reliable estimation?
    Price OH; Carville KS; Sullivan SG
    Commun Dis Intell (2018); 2019 May; 43():. PubMed ID: 31091402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan.
    Saito N; Komori K; Suzuki M; Morimoto K; Kishikawa T; Yasaka T; Ariyoshi K
    Vaccine; 2017 Jan; 35(4):687-693. PubMed ID: 28043738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
    Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.